PL1636190T3 - Trwały kryształ związku 4-oksochinoliny - Google Patents

Trwały kryształ związku 4-oksochinoliny

Info

Publication number: PL1636190T3
Authority: PL; Poland
Prior art keywords: stable crystal; oxoquinoline compound; oxoquinoline; compound; crystal
Prior art date: 2004-05-20

Application number

PL05726243T

Other languages

English (en)

Inventor

Motohide Satoh

Takahisa Motomura

Takashi Matsuda

Kentaro Kondo

Koji Ando

Koji Matsuda

Shuji Miyake

Hideto Uehara

Original Assignee

Japan Tobacco Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-20

Filing date

2005-05-19

Publication date

2012-10-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35079161&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1636190(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-05-19 Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc

2012-10-31 Publication of PL1636190T3 publication Critical patent/PL1636190T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)

PL05726243T 2004-05-20 2005-05-19 Trwały kryształ związku 4-oksochinoliny PL1636190T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2004150979		2004-05-20
PCT/JP2005/009604 WO2005113508A1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound
EP05726243A EP1636190B1 (en)	2004-05-20	2005-05-19	Stable crystal of 4-oxoquinoline compound

Publications (1)

Publication Number	Publication Date
PL1636190T3 true PL1636190T3 (pl)	2012-10-31

Family

ID=35079161

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL05726243T PL1636190T3 (pl)	2004-05-20	2005-05-19	Trwały kryształ związku 4-oksochinoliny
PL17186674.2T PL3281939T3 (pl)	2004-05-20	2005-05-19	Kombinacja zawierająca trwały kryształ związku 4-oksochinolinowego

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL17186674.2T PL3281939T3 (pl)	2004-05-20	2005-05-19	Kombinacja zawierająca trwały kryształ związku 4-oksochinolinowego

Country Status (33)

Country	Link
US (7)	US7635704B2 (pl)
EP (4)	EP1636190B1 (pl)
JP (1)	JP3754064B2 (pl)
KR (1)	KR20080064909A (pl)
CN (1)	CN1956961B (pl)
AR (2)	AR049280A1 (pl)
AU (1)	AU2005245296B2 (pl)
BE (1)	BE2024C511I2 (pl)
BR (1)	BRPI0510114B8 (pl)
CA (1)	CA2566922C (pl)
CY (4)	CY1113010T1 (pl)
DK (2)	DK1636190T3 (pl)
ES (2)	ES2960824T3 (pl)
FI (2)	FI3281939T3 (pl)
FR (1)	FR23C1040I1 (pl)
HR (2)	HRP20120681T1 (pl)
HU (2)	HUE064615T2 (pl)
IL (1)	IL179250A0 (pl)
LT (2)	LT3281939T (pl)
LU (1)	LUC00334I2 (pl)
MX (1)	MXPA06013405A (pl)
MY (1)	MY134672A (pl)
NO (8)	NO339223B1 (pl)
NZ (1)	NZ551839A (pl)
PE (2)	PE20120361A1 (pl)
PL (2)	PL1636190T3 (pl)
PT (2)	PT3281939T (pl)
RS (2)	RS52375B (pl)
RU (1)	RU2330845C1 (pl)
SI (2)	SI3281939T1 (pl)
TW (1)	TWI329015B (pl)
WO (1)	WO2005113508A1 (pl)
ZA (1)	ZA200610647B (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6891227B2 (en)	2002-03-20	2005-05-10	International Business Machines Corporation	Self-aligned nanotube field effect transistor and method of fabricating same
PE20040840A1 (es) *	2002-11-20	2004-12-30	Japan Tobacco Inc	Derivados de 4-oxoquinolina como inhibidores de la integrasa del vih
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
WO2007063869A1 (ja) *	2005-11-30	2007-06-07	Japan Tobacco Inc.	高純度キノロン化合物の製造方法
US20090233964A1 (en) *	2005-12-30	2009-09-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
AU2013203476C1 (en) *	2005-12-30	2016-11-17	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
CA2847871C (en)	2005-12-30	2016-07-26	Gilead Sciences, Inc.	Methods for improving the pharmacokinetics of hiv integrase inhibitors
US20090018162A1 (en) *	2006-02-01	2009-01-15	Yuji Matsuzaki	Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
WO2007092802A1 (en) *	2006-02-09	2007-08-16	Boehringer Ingelheim International Gmbh	Method for treating hiv infection through co-administration of tipranavir and gs 9137
IN2014CN00532A (pl)	2006-03-06	2015-04-03	Japan Tobacco Inc
PL1992607T3 (pl)	2006-03-06	2015-05-29	Japan Tobacco Inc	Sposób wytwarzania związku 4-oksochinolinowego
CN103275033B (zh)	2006-07-07	2015-04-29	吉里德科学公司	治疗剂的药代动力学特性调节剂
CA2661943C (en)	2006-09-12	2015-11-03	Gilead Sciences, Inc.	Process and intermediates for preparing integrase inhibitors
AP2986A (en) *	2007-02-23	2014-09-30	Gilead Sciences Inc	Modulators of pharmacokinetic properties of therapeutics
MX2009013828A (es) *	2007-06-29	2010-03-10	Gilead Sciences Inc	Composiciones terapeuticas y su uso.
CN101686972B (zh) *	2007-06-29	2013-08-14	吉里德科学公司	治疗用组合物和方法
AR068403A1 (es)	2007-09-11	2009-11-18	Gilead Sciences Inc	Proceso e intermediarios para la preparacion de inhibidores de integrasa
MX342377B (es)	2008-05-02	2016-09-27	Gilead Sciences Inc	Uso de particulas trasportadoras solidas para mejorar la capacidad de procesamiento de un agente farmaceutico.
WO2010091197A2 (en)	2009-02-06	2010-08-12	Gilead Sciences, Inc.	Tablets for combination therapy
WO2010137032A2 (en) *	2009-05-14	2010-12-02	Matrix Laboratories Ltd.	Novel polymorphic forms of elvitegravir and its pharmaceutically acceptable salts
WO2011004389A2 (en) *	2009-06-18	2011-01-13	Matrix Laboratories Ltd	An improved process for the preparation of elvitegravir
CN102212032B (zh) *	2011-04-20	2013-07-31	复旦大学	一种5-羟基喹诺酮类衍生物及其制备方法和用途
CA2878478A1 (en)	2012-07-06	2014-01-09	Genentech, Inc.	N-substituted benzamides and methods of use thereof
PT2880017T (pt)	2012-08-03	2016-12-14	Gilead Sciences Inc	Processo e intermediários para preparar inibidores da integrase
CN103819402B (zh) *	2012-11-17	2016-03-30	上海迪赛诺化学制药有限公司	埃替拉韦中间体及其制备方法和应用
CN103864682B (zh) *	2012-12-18	2016-12-28	上海迪赛诺化学制药有限公司	一种制备iii型埃替拉韦晶体的方法
PH12019501848A1 (en)	2012-12-21	2020-03-02	Gilead Sciences Inc	Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
NO2865735T3 (pl)	2013-07-12	2018-07-21
WO2015006731A1 (en)	2013-07-12	2015-01-15	Gilead Sciences, Inc.	Polycyclic-carbamoylpyridone compounds and their use for the treatment of hiv infections
CN105315203A (zh) *	2014-06-06	2016-02-10	上海迪赛诺化学制药有限公司	一种v型埃替拉韦晶体及其制备方法
TW201613936A (en)	2014-06-20	2016-04-16	Gilead Sciences Inc	Crystalline forms of(2R,5S,13aR)-8-hydroxy-7,9-dioxo-n-(2,4,6-trifluorobenzyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepine-10-carboxamide
TWI744723B (zh)	2014-06-20	2021-11-01	美商基利科學股份有限公司	多環型胺甲醯基吡啶酮化合物之合成
NO2717902T3 (pl)	2014-06-20	2018-06-23
TWI695003B (zh)	2014-12-23	2020-06-01	美商基利科學股份有限公司	多環胺甲醯基吡啶酮化合物及其醫藥用途
BR112017020837A2 (pt)	2015-04-02	2018-07-03	Gilead Sciences, Inc.	compostos de carbamoilpiridona policíclicos e seu uso farmacêutico
CN106008195B (zh) *	2016-05-19	2018-08-03	绍兴文理学院	一种2，4-二氟-5-碘苯甲酸的制备方法
EP3984536B1 (en) *	2020-10-19	2025-06-25	Centre national de la recherche scientifique	Inhibition of the hiv-1 replication by compounds directed against a new target of the viral cycle

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3472859A (en) *	1966-11-01	1969-10-14	Sterling Drug Inc	1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
JPS567162B1 (pl)	1970-09-14	1981-02-16
JPS4826772A (pl)	1971-08-11	1973-04-09
JPS6450979A (en)	1987-08-21	1989-02-27	Hitachi Shipbuilding Eng Co	Method for discriminating whistle sound
JPH0651229B2 (ja)	1989-07-31	1994-07-06	新日本製鐵株式会社	プラズマアーク溶接方法および装置
IL100555A (en)	1991-02-07	2000-08-31	Hoechst Marion Roussel Inc	N-substituted quinoline derivatives their preparation their use for the preparation of medicaments and the pharmaceutical compositions containing them
JP2993316B2 (ja)	1992-05-27	1999-12-20	宇部興産株式会社	アリール基又は複素芳香環基置換アミノキノロン誘導体及びエイズ治療剤
NO304832B1 (no)	1992-05-27	1999-02-22	Ube Industries	Aminokinolonderivater samt middel mot HIV
JPH06199835A (ja)	1993-01-08	1994-07-19	Hokuriku Seiyaku Co Ltd	８−ジフルオロメトキシキノリン−３−カルボン酸誘導体
JPH06271568A (ja)	1993-03-22	1994-09-27	Hokuriku Seiyaku Co Ltd	７−フェニルピペラジニルキノリン−３−カルボン酸誘導体
JP2930539B2 (ja)	1994-07-18	1999-08-03	三共株式会社	トリフルオロメチルキノリンカルボン酸誘導体
AU683569B2 (en)	1994-07-18	1997-11-13	Sankyo Company Limited	Trifluoromethylquinolinecarboxylic acid derivative
JPH0826772A (ja)	1994-07-22	1996-01-30	Sony Corp	融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
EP0892801B1 (en)	1996-04-12	2002-01-02	THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Acridone-derived compounds useful as antineoplastic and antiretroviral agents
FR2761687B1 (fr)	1997-04-08	2000-09-15	Centre Nat Rech Scient	Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
JP3776203B2 (ja)	1997-05-13	2006-05-17	第一製薬株式会社	Ｉｃａｍ−１産生阻害剤
GB9721964D0 (en)	1997-10-16	1997-12-17	Pfizer Ltd	Isoquinolines
US6399629B1 (en)	1998-06-01	2002-06-04	Microcide Pharmaceuticals, Inc.	Efflux pump inhibitors
SE9802549D0 (sv) *	1998-07-15	1998-07-15	Active Biotech Ab	Quinoline derivatives
US6248739B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	Quinolinecarboxamides as antiviral agents
US6248736B1 (en)	1999-01-08	2001-06-19	Pharmacia & Upjohn Company	4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
PE20011349A1 (es)	2000-06-16	2002-01-19	Upjohn Co	1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
US6559145B2 (en)	2000-07-12	2003-05-06	Pharmacia & Upjohn Company	Heterocycle carboxamides as antiviral agents
JP2004513134A (ja)	2000-10-12	2004-04-30	メルク　エンド　カムパニー　インコーポレーテッド	Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルケトン類
ATE345129T1 (de)	2000-10-12	2006-12-15	Merck & Co Inc	Aza- und polyaza-naphthalenylcarbonsäureamide als hiv-integrase-hemmer
ATE411292T1 (de)	2001-03-01	2008-10-15	Shionogi & Co	Stickstoffhaltige heteroarylverbindungen mit hiv- integrase inhibierender wirkung
JP2002293745A (ja)	2001-03-29	2002-10-09	St Marianna Univ School Of Medicine	慢性関節リウマチ治療剤
US20030138483A1 (en) *	2001-05-25	2003-07-24	Sergio Petriconi	Soft elastic capsules and compositions thereof
US6627646B2 (en) *	2001-07-17	2003-09-30	Sepracor Inc.	Norastemizole polymorphs
FR2827600A1 (fr)	2001-07-20	2003-01-24	Lipha	Derives acides de quinolone et leurs applications en therapeutique
RU2206564C1 (ru) *	2002-03-07	2003-06-20	Общество с ограниченной ответственностью "Поливит"	Способ получения этилового эфира 6-фтор-7-хлор-1,4-дигидро-4-оксо-3-хинолинкарбоновой кислоты
JP4035765B2 (ja)	2002-10-31	2008-01-23	横河電機株式会社	フーリエ変換型赤外線分光計
JP3567162B1 (ja)	2002-11-20	2004-09-22	日本たばこ産業株式会社	４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
PE20040840A1 (es)	2002-11-20	2004-12-30	Japan Tobacco Inc	Derivados de 4-oxoquinolina como inhibidores de la integrasa del vih
WO2005113509A1 (en) *	2004-05-20	2005-12-01	Japan Tobacco Inc.	Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
MY134672A (en) *	2004-05-20	2007-12-31	Japan Tobacco Inc	Stable crystal of 4-oxoquinoline compound
JP4629104B2 (ja)	2004-05-21	2011-02-09	日本たばこ産業株式会社	４−オキソキノリン誘導体および抗ｈｉｖ剤を含む併用剤

2005
- 2005-05-18 MY MYPI20052258A patent/MY134672A/en unknown
- 2005-05-19 KR KR1020087014768A patent/KR20080064909A/ko not_active Withdrawn
- 2005-05-19 DK DK05726243.8T patent/DK1636190T3/da active
- 2005-05-19 AR ARP050102058A patent/AR049280A1/es not_active Application Discontinuation
- 2005-05-19 HU HUE17186674A patent/HUE064615T2/hu unknown
- 2005-05-19 ZA ZA200610647A patent/ZA200610647B/en unknown
- 2005-05-19 CN CN2005800161426A patent/CN1956961B/zh not_active Expired - Lifetime
- 2005-05-19 FI FIEP17186674.2T patent/FI3281939T3/fi active
- 2005-05-19 ES ES17186674T patent/ES2960824T3/es not_active Expired - Lifetime
- 2005-05-19 PT PT171866742T patent/PT3281939T/pt unknown
- 2005-05-19 EP EP05726243A patent/EP1636190B1/en not_active Expired - Lifetime
- 2005-05-19 SI SI200532315T patent/SI3281939T1/sl unknown
- 2005-05-19 RS RS20120306A patent/RS52375B/sr unknown
- 2005-05-19 MX MXPA06013405A patent/MXPA06013405A/es active IP Right Grant
- 2005-05-19 HR HRP20120681TT patent/HRP20120681T1/hr unknown
- 2005-05-19 TW TW094116234A patent/TWI329015B/zh not_active IP Right Cessation
- 2005-05-19 EP EP17186674.2A patent/EP3281939B1/en not_active Expired - Lifetime
- 2005-05-19 CA CA2566922A patent/CA2566922C/en not_active Expired - Lifetime
- 2005-05-19 PT PT05726243T patent/PT1636190E/pt unknown
- 2005-05-19 PL PL05726243T patent/PL1636190T3/pl unknown
- 2005-05-19 SI SI200531572T patent/SI1636190T1/sl unknown
- 2005-05-19 JP JP2005147219A patent/JP3754064B2/ja not_active Expired - Lifetime
- 2005-05-19 LT LTEP17186674.2T patent/LT3281939T/lt unknown
- 2005-05-19 EP EP23203885.1A patent/EP4299563A3/en active Pending
- 2005-05-19 RU RU2006145302/04A patent/RU2330845C1/ru active
- 2005-05-19 HR HRP20231588TT patent/HRP20231588T3/hr unknown
- 2005-05-19 BR BRPI0510114A patent/BRPI0510114B8/pt active IP Right Grant
- 2005-05-19 WO PCT/JP2005/009604 patent/WO2005113508A1/en not_active Ceased
- 2005-05-19 NZ NZ551839A patent/NZ551839A/en not_active IP Right Cessation
- 2005-05-19 AU AU2005245296A patent/AU2005245296B2/en active Active
- 2005-05-19 PL PL17186674.2T patent/PL3281939T3/pl unknown
- 2005-05-19 DK DK17186674.2T patent/DK3281939T3/da active
- 2005-05-19 EP EP12173572A patent/EP2514746A1/en not_active Withdrawn
- 2005-05-19 RS RS20231092A patent/RS64845B1/sr unknown
- 2005-05-19 ES ES05726243T patent/ES2388441T3/es not_active Expired - Lifetime
- 2005-05-20 PE PE2011002129A patent/PE20120361A1/es active IP Right Grant
- 2005-05-20 US US11/133,471 patent/US7635704B2/en active Active
- 2005-05-20 PE PE2005000561A patent/PE20060358A1/es active IP Right Grant
2006
- 2006-11-14 IL IL179250A patent/IL179250A0/en active IP Right Grant
- 2006-12-14 NO NO20065790A patent/NO339223B1/no unknown
2009
- 2009-08-10 US US12/538,694 patent/US8981103B2/en active Active
2012
- 2012-07-11 CY CY20121100621T patent/CY1113010T1/el unknown
2014
- 2014-04-25 AR ARP140101722A patent/AR096100A2/es active IP Right Grant
2015
- 2015-01-09 US US14/593,946 patent/US20150361044A1/en not_active Abandoned
2016
- 2016-08-12 NO NO20161297A patent/NO20161297A1/no not_active Application Discontinuation
2017
- 2017-03-01 US US15/447,007 patent/US20180029989A1/en not_active Abandoned
2018
- 2018-07-20 US US16/041,458 patent/US20190185433A1/en not_active Abandoned
2019
- 2019-01-15 NO NO20190051A patent/NO20190051A1/no not_active Application Discontinuation
2020
- 2020-08-04 NO NO20200873A patent/NO20200873A1/no not_active Application Discontinuation
2021
- 2021-08-24 US US17/445,817 patent/US20220235009A1/en not_active Abandoned
2022
- 2022-06-17 NO NO20220690A patent/NO20220690A1/no not_active Application Discontinuation
2023
- 2023-08-25 NO NO20230913A patent/NO347902B1/no unknown
- 2023-09-28 CY CY2015009C patent/CY2015009I2/el unknown
- 2023-11-02 FR FR23C1040C patent/FR23C1040I1/fr active Active
- 2023-12-05 CY CY20231100714T patent/CY1126560T1/el unknown
2024
- 2024-03-14 LU LU00334C patent/LUC00334I2/fr unknown
- 2024-03-15 BE BE2024C511C patent/BE2024C511I2/nl unknown
- 2024-03-19 CY CY2024008C patent/CY2024008I2/el unknown
- 2024-03-20 HU HUS2400006C patent/HUS2400006I1/hu unknown
- 2024-03-20 FI FIC20240008C patent/FIC20240008I1/fi unknown
- 2024-03-26 LT LTPA2024001C patent/LTC3281939I2/lt unknown
- 2024-04-12 US US18/634,451 patent/US20250091995A1/en active Pending
- 2024-04-22 NO NO20240384A patent/NO20240384A1/no unknown
- 2024-07-15 NO NO2024034C patent/NO2024034I1/no unknown

Also Published As

Publication number	Publication date
IL179250A0 (en)	2007-03-08
US20060030710A1 (en)	2006-02-09
CY2015009I1 (el)	2024-09-20
NO339223B1 (no)	2016-11-21
AU2005245296B2 (en)	2010-08-12
HUS2400006I1 (hu)	2024-04-28
NO20200873A1 (no)	2007-02-07
CY1126560T1 (el)	2024-09-20
JP3754064B2 (ja)	2006-03-08
LTC3281939I2 (pl)	2025-04-25
PE20120361A1 (es)	2012-05-03
KR20080064909A (ko)	2008-07-09
EP1636190B1 (en)	2012-06-27
AU2005245296A1 (en)	2005-12-01
HRP20231588T3 (hr)	2024-03-15
EP4299563A3 (en)	2024-02-28
US20150361044A1 (en)	2015-12-17
MXPA06013405A (es)	2007-03-01
LTPA2024001I1 (pl)	2024-04-10
CN1956961A (zh)	2007-05-02
US20250091995A1 (en)	2025-03-20
RU2330845C1 (ru)	2008-08-10
AR096100A2 (es)	2015-12-09
US7635704B2 (en)	2009-12-22
CA2566922A1 (en)	2005-12-01
NO20220690A1 (no)	2007-02-07
US20180029989A1 (en)	2018-02-01
EP2514746A1 (en)	2012-10-24
NO20230913A1 (no)	2007-02-07
HRP20120681T1 (hr)	2012-09-30
PL3281939T3 (pl)	2024-03-18
DK1636190T3 (da)	2012-09-24
EP3281939B1 (en)	2023-10-18
US20100204271A1 (en)	2010-08-12
TWI329015B (en)	2010-08-21
EP4299563A2 (en)	2024-01-03
FR23C1040I1 (fr)	2023-12-29
JP2006001927A (ja)	2006-01-05
PT3281939T (pt)	2023-11-22
ZA200610647B (en)	2008-06-25
CY2024008I1 (el)	2024-09-20
NO20190051A1 (no)	2007-02-07
EP3281939A1 (en)	2018-02-14
WO2005113508A1 (en)	2005-12-01
SI3281939T1 (sl)	2024-02-29
PE20060358A1 (es)	2006-05-12
BRPI0510114B1 (pt)	2020-09-15
EP1636190A1 (en)	2006-03-22
CY2015009I2 (el)	2024-09-20
ES2388441T3 (es)	2012-10-15
BE2024C511I2 (pl)	2024-10-08
NO20065790L (no)	2007-02-07
LUC00334I2 (pl)	2024-07-01
MY134672A (en)	2007-12-31
CN1956961B (zh)	2010-05-26
NO20240384A1 (no)	2007-02-07
AR049280A1 (es)	2006-07-12
DK3281939T3 (da)	2024-01-22
CY2024008I2 (el)	2024-09-20
CY1113010T1 (el)	2016-04-13
BRPI0510114B8 (pt)	2021-05-25
BRPI0510114A (pt)	2007-09-25
PT1636190E (pt)	2012-08-20
US8981103B2 (en)	2015-03-17
NO2024034I1 (no)	2024-07-15
NO347902B1 (no)	2024-05-06
ES2960824T3 (es)	2024-03-06
HUE064615T2 (hu)	2024-04-28
SI1636190T1 (sl)	2012-09-28
FI3281939T3 (fi)	2023-10-23
LT3281939T (lt)	2023-11-27
TW200600097A (en)	2006-01-01
NO20161297A1 (no)	2007-02-07
FIC20240008I1 (fi)	2024-03-20
RS52375B (sr)	2012-12-31
US20220235009A1 (en)	2022-07-28
RS64845B1 (sr)	2023-12-29
NZ551839A (en)	2009-11-27
HK1083341A1 (en)	2006-06-30
US20190185433A1 (en)	2019-06-20
CA2566922C (en)	2011-01-11

Publication	Publication Date	Title
PL1636190T3 (pl)	2012-10-31	Trwały kryształ związku 4-oksochinoliny
DE602005015215D1 (de)	2009-08-13	Orthosubstituierte aryl- oder heteroarylamidverbindungen
DK1809978T3 (da)	2014-01-20	Modul-skydebane
DE602006004463D1 (de)	2009-02-05	Kristallform von asenapinmaleat
DK1917227T3 (da)	2013-05-27	Krystalformer af astaxanthin
DE602005009127D1 (de)	2008-10-02	Siliziumverbindung
NO20070299L (no)	2007-03-26	Novel heterocyclic compounds
NO20043305D0 (no)	2004-08-09	Preparation of lodixanol
ATE404546T1 (de)	2008-08-15	Substituierte n-sulfonylaminobenzyl-2- phenoxyacetamidverbindungen
DE602005018653D1 (de)	2010-02-11	Aktive auswahl der bestätigungsquelle
DE502005005664D1 (de)	2008-11-27	Chronograph
DE602005012754D1 (de)	2009-04-02	Kristalloszillator
FR2877833B1 (fr)	2007-10-12	Correcteur de lordoses
IS7963A (is)	2005-07-28	Efnasambönd með hamlandi virkni gegn prólýlólígópeptíðasa
SE0402103D0 (sv)	2004-08-30	Novel compounds
ATE384719T1 (de)	2008-02-15	Dioxazinyl-substituierte thienylsulfonylaminocarbonylverbindungen
SE0400022D0 (sv)	2004-01-08	New compounds
SE0400254D0 (sv)	2004-02-06	New compounds
ITVR20040028A1 (it)	2004-06-02	Struttura di longherone
SE0402068D0 (sv)	2004-08-24	Novel compounds
SE0403054D0 (sv)	2004-12-15	Novel compounds
SE0400286D0 (sv)	2004-02-11	Novel Compounds
SE0401348D0 (sv)	2004-05-26	Novel compounds
SE0401885D0 (sv)	2004-07-19	Novel compounds
SE0402069D0 (sv)	2004-08-24	Novel compounds